MagQu Company Profile: Funding, Investors & Partnerships

MagQu

Since the start-up in 2008, MagQu has utilized her core technology, so-called ImmunoMagnetic Reduction (IMR), to develop dozens of products, such as in-vitro diagnostic (IVD) assay kits and analyzers for colorectal cancer, Alzheimer’s disease, Down’s syndrome, preterm birth, inflammatory disease, grouper viruses etc.Since the start-up in 2008, MagQu has utilized her core technology, so-called ImmunoMagnetic Reducti Show More

Alpha Score

37.6